AGALIMMUNE
Agalimmune was established in 2013. Its shareholders include Loxbridge Research LLP and Animatrix Capital LLP which invest in innovative medical technologies. Agalimmune is located in London, UK and California, USA. Agalimmune has licensed the Alphaject™ immunotherapeutic technology from the University of Massachusetts Medical School, Worcester, MA (USA) where it was researched and developed by a team, led by Professor Uri Galili. The goal of Alphaject™ therapy is to convert the injected tumor into a vaccine that “instructs” the immune system of patients with solid tumors to recognize metastatic tumor cells and destroy them. This treatment may also bring about a long lasting protective anti-tumor immune response.
AGALIMMUNE
Social Links:
Industry:
Biotechnology Health Care
Founded:
2013-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.agalimmune.com
Total Employee:
1+
Status:
Closed
Contact:
+972-8-642-9100
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail Pound Sterling GoDaddy DNS AWS Global Accelerator
Official Site Inspections
http://www.agalimmune.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Agalimmune"
Agalimmune - Crunchbase Company Profile & Funding
Agalimmune was established in 2013. Its shareholders include Loxbridge Research LLP and Animatrix Capital LLP which invest in innovative medical technologies. Agalimmune is located …See details»
AGALIMMUNE LTD. overview - Find and update company …
Charges for AGALIMMUNE LTD. (08504603) More for AGALIMMUNE LTD. (08504603) Registered office address First Floor, 5 Fleet Place, London, United Kingdom, EC4M 7RD . …See details»
Agalimmune 2025 Company Profile: Valuation, Investors
Agalimmune was founded in 2013. Where is Agalimmune headquartered? Agalimmune is headquartered in Sandwich, United Kingdom. What is the size of Agalimmune? Agalimmune …See details»
BioLineRx Announces Acquisition of Agalimmune Ltd. to …
Mar 23, 2017 About Agalimmune and AGI-134 . Agalimmune Ltd. is a biopharmaceutical company with an innovative anti-cancer immunotherapy pipeline for generating a systemic, …See details»
AGALIMMUNE LTD. Company Profile - Dun & Bradstreet
AGALIMMUNE LTD. Company Profile | LONDON, United Kingdom | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Agalimmune - Ownership and Business Overview - Mergr
Agalimmune Ltd. is a biopharmaceutical company with an innovative anti-cancer immunotherapy pipeline for generating a systemic, adaptive immune response to solid tumors. It was …See details»
Agalimmune Limited Founded To Develop Immunotherapeutics …
Nov 26, 2013 Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors. The Company’s vision is to harness …See details»
Agalimmune - Products, Competitors, Financials, Employees, …
Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors. The Company's vision is to harness the power of the …See details»
Agalimmune - VentureRadar
"BioLineRx is a clinical-stage biopharmaceutical company focused on oncology and immunology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical …See details»
Agalimmune Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jul 5, 2023 Explore Agalimmune Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 4 literature, Disease Domain:Neoplasms ...See details»
Agalimmune - Drug pipelines, Patents, Clinical trials - Synapse
Explore Agalimmune with its drug pipeline, therapeutic area, technology platform, .See details»
AGALIMMUNE LTD. more information - Find and update company …
AGALIMMUNE LTD. - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Agalimmune — Oxford Cancer
Agalimmune were a small biotech company at an early stage of development of a rabbit poly-clonal antibody-based therapy. They approached Oxford cancer researchers who advised on …See details»
BioLineRx Announces Acquisition of Agalimmune Ltd.
Mar 24, 2017 Agalimmune’s lead compound is AGI-134, a synthetic alpha-Gal immunotherapy in development for solid tumors. AGI-134 harnesses the body’s pre-existing, highly abundant anti …See details»
Agalimmune Ltd. - Golden
Agalimmune Ltd. is a company founded in 2013. 1St Floor Thavies Inn House, 3-4 Holborn Circus, London, EC1N 2HASee details»
BiolineRx acquires Agalimmune, a licensee using Kode ... - Kode …
Mar 23, 2017 In 2015, Agalimmune negotiated exclusive rights to use Kode Biotech’s Function-Spacer-Lipid (FSL) cell-surface membrane modification technology for use with intratumorally …See details»
BioLineRx Buys U.K. Cancer Immunotherapeutics Firm Agalimmune
Mar 23, 2017 BioLineRx has bought U.K. anticancer company Agalimmune for $6 million in a 50/50 cash and shares-based deal to acquire its immunotherapy platform and late preclinical …See details»
BioLineRx buys Agalimmune to expand cancer pipeline
Mar 23, 2017 BioLineRx has bought Agalimmune to expand its immuno-oncology pipeline. The takeover adds the synthetic alpha-gal immunotherapy AGI-134 to BioLineRx’s pipeline as the …See details»
Agalimmune Limited Licenses KODE Biotech’s FSL Technology
Jun 15, 2015 Agalimmune has exclusive rights to the use of the technology in the field of intratumoral injection for cancer treatment, and specifically relating to the clinical candidate …See details»
Agalimmune licenses KODE Biotech’s FSL technology
Jun 16, 2015 Agalimmune has licensed KODE Biotech’s Function-Spacer-Lipid (FSL) cell surface membrane modification technology (KODE™ Technology).. The proprietary …See details»